The University of New South Wales

Cuprior Shows Promise in Treating High-Risk Neuroblastoma in Children

5 months ago

• A new study suggests that triethylenetetramine (TETA), known as Cuprior, can improve outcomes for children with high-risk neuroblastoma. • Cuprior weakens tumors by transferring copper to immune cells and boosts the immune system's ability to fight the disease. • Researchers suggest Cuprior could improve current immunotherapy results, potentially increasing survival rates from 10 to 50 percent. • Repurposing existing drugs like Cuprior saves time and money compared to developing new treatments, offering a non-toxic option with minimal side effects.